Clinical trial
A Pilot Trial of Galcanezumab for Vestibular Migraine
NCT04417361 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Trial of Galcanezumab for Vestibular Migraine
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 18, 2020
- Completion date
- September 29, 2023
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.